Fig. 5

In vivo anti-tumor efficiency of HPNDs@EcN. (A) Schematic diagram of the treatment process of tumor-bearing mice. (B) Body weight curve of tumor-bearing mice. (C) Tumor volume growth curve of tumor-bearing mice. (D) Survival curve of tumor-bearing mice. (E) Tumor growth of each group of tumor-bearing mice after the end of treatment. (F) H&E staining, TUNEL immunofluorescence staining, Ki67 immunohistochemical staining of tumor sections from tumor-bearing mice after receiving different treatment regimens. (*** p < 0.001)